(Q73729436)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309534%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309534%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

1 reference

N Custro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309534%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

G Montalto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309534%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

V Scafidi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309534%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Soresi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309534%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

S Gallo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309534%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

S Tripi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309534%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Notarbartolo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309534%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 July 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309534%20AND%20SRC:MED&resulttype=core&format=json

Journal of Endocrinological Investigation

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309534%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309534%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

374-380

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309534%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309534%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf03347987

6 November 2019

exact match

0 references

cites work

High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy

1 reference

12 December 2020

Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C

1 reference

12 December 2020

Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha

1 reference

12 December 2020

Subclinical hypothyroidism resulting from autoimmune thyroiditis in female patients with endogenous depression

1 reference

12 December 2020

Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction

1 reference

12 December 2020

Thyroid antibodies in blood donors: prevalence and clinical significance

1 reference

12 December 2020

Immunological aspects of chronic active hepatitis.

1 reference

12 December 2020

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis

1 reference

12 December 2020

Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies, and other autoantibodies in patients with ulcerative colitis

1 reference

12 December 2020

Side effects of alpha interferon

1 reference

12 December 2020

Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C.

1 reference

12 December 2020

Latent autoimmune thyroid disease in patients with chronic HCV hepatitis

1 reference

12 December 2020

High prevalence of antibodies to hepatitis C virus (HCV) in patients with anti-thyroid autoantibodies

1 reference

12 December 2020

Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon

1 reference

12 December 2020

An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer

1 reference

12 December 2020

Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy

1 reference

12 December 2020

Hepatitis C virus, interferon alpha, and dysthyroidism

1 reference

12 December 2020

Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis

1 reference

12 December 2020

Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors

1 reference

12 December 2020

The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C

1 reference

12 December 2020

Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis

1 reference

12 December 2020

Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon

1 reference

12 December 2020

Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa

1 reference

12 December 2020

Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha

1 reference

12 December 2020

Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03347987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9309534%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 November 2019

0 references

1 reference